Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELLEBRATE: AMDC-USR vs Placebo in SUI
NCT03104517Phase 3Active, not recruiting
- Sponsor
- Cook MyoSite
- Start
- Apr 2019
- Primary completion
- Jun 2026
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in stress urinary incontinence (SUI) comparing AMDC-USR (iltamiocel) with Placebo (2 arms). Primary endpoint: Number of leaks due to stress incontinence episodes at 12 months. Started Apr 2019; status: active, not recruiting.
02
Drugs
AMDC-USR
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT03104517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104517.